Evaluate the efficacy of Amrutanagaradi Kwatha in the management of Eka Kushtha (Psoriasis)

Randomized controlled clinical trial to evaluate the efficacy of Amrutanagaradi Kwatha in the management of Eka Kushtha (Psoriasis) - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087282

Enrollment

Registered

2025-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue Health Condition 2: L409- Psoriasis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients irrespective of gender and religion will be selected. 2)Patients having clinical features of Eka kushtha such as Mahavastu(Extent of lesion) and Matsyashakalopama(Scaling), Aswedanam(Unhydrosis), Krushnaaruna varna(Erythema). 3)Patients showing sign and symptoms of Psoriasis less than 2 years.

Exclusion criteria

Exclusion criteria: 1)Patients below 20 year and above the age 55 year of age. 2)Patients with pregnancy and lactation. 3)Patients suffering from Psoriatic arthritis, Tinea corporis, Eczema, Lichen planus, Contact dermatitis. 4)Patients on steroids for more than one year.

Design outcomes

Primary

Measure	Time frame
Matsyashakalopam (scaling), Krushnaaruna Varna (Erythema) This Symptoms Will Be ReducedTimepoint: 45 Days	—

Secondary

Measure	Time frame
Mahavastu(Extent of lesion) This Symptom Will Be ReducedTimepoint: 45 Days	—

Countries

India

Contacts

Public ContactDr Arti Sominath Maske

C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra

ayushakti009@gmail.com9422711098

Outcome results